$SDST
Stardust Power Inc.

2022 Q3 Form 10-Q Financial Statement

#000121390022069750 Filed on November 07, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2021 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.210M $992.0K
YoY Change 21.98%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.210M $992.0K
YoY Change 21.98%
Operating Profit -$1.210M -$992.0K
YoY Change 21.98%
Interest Expense $1.466M $8.000K
YoY Change 18225.0%
% of Operating Profit
Other Income/Expense, Net $1.868M $2.490M
YoY Change -24.98%
Pretax Income $2.124M $1.506M
YoY Change 41.04%
Income Tax
% Of Pretax Income
Net Earnings $2.124M $1.506M
YoY Change 41.04%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $56.64K $40.16K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $247.0K $969.0K
YoY Change -74.51%
Cash & Equivalents $247.0K $969.0K
Short-Term Investments
Other Short-Term Assets $69.00K $256.0K
YoY Change -73.05%
Inventory
Prepaid Expenses $69.00K
Receivables
Other Receivables
Total Short-Term Assets $316.0K $1.225M
YoY Change -74.2%
LONG-TERM ASSETS
Property, Plant & Equipment $5.000M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $302.0M $300.1M
YoY Change 0.65%
Other Assets
YoY Change
Total Long-Term Assets $302.0M $300.1M
YoY Change 0.65%
TOTAL ASSETS
Total Short-Term Assets $316.0K $1.225M
Total Long-Term Assets $302.0M $300.1M
Total Assets $302.3M $301.3M
YoY Change 0.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $395.0K
YoY Change
Accrued Expenses $3.035M $2.752M
YoY Change 10.28%
Deferred Revenue
YoY Change
Short-Term Debt $400.0K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.830M $2.752M
YoY Change 39.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.43M $24.20M
YoY Change -52.75%
Total Long-Term Liabilities $11.43M $24.20M
YoY Change -52.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.830M $2.752M
Total Long-Term Liabilities $11.43M $24.20M
Total Liabilities $15.26M $26.95M
YoY Change -43.36%
SHAREHOLDERS EQUITY
Retained Earnings -$14.95M
YoY Change
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$14.95M $274.3M
YoY Change
Total Liabilities & Shareholders Equity $302.3M $301.3M
YoY Change 0.35%

Cashflow Statement

Concept 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $2.124M $1.506M
YoY Change 41.04%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$542.0K -$292.0K
YoY Change 85.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 400.0K 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -542.0K -292.0K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 400.0K 0.000
Net Change In Cash -142.0K -292.0K
YoY Change -51.37%
FREE CASH FLOW
Cash From Operating Activities -$542.0K -$292.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39875
dei Entity Registrant Name
EntityRegistrantName
GLOBAL PARTNER ACQUISITION CORP II
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Address Address Line1
EntityAddressAddressLine1
7 Rye Ridge Plaza
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 350
dei Entity Address City Or Town
EntityAddressCityOrTown
Rye Brook
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10537
dei City Area Code
CityAreaCode
(917)
dei Local Phone Number
LocalPhoneNumber
793-1965
dei Security12b Title
Security12bTitle
Class A ordinary shares
dei Trading Symbol
TradingSymbol
GPAC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q3 us-gaap Cash
Cash
247000 usd
CY2021Q4 us-gaap Cash
Cash
842000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
69000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
183000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
316000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1025000 usd
CY2022Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
302021000 usd
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
300075000 usd
CY2022Q3 us-gaap Assets
Assets
302337000 usd
CY2021Q4 us-gaap Assets
Assets
301100000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
395000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
135000 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
400000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3035000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2673000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3830000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2808000 usd
CY2022Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
934000 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
12920000 usd
CY2022Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
10500000 usd
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
10500000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
15264000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
26228000 usd
CY2022Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
302021000 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
300000000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 gpac Common Stock One Value
CommonStockOneValue
1000 usd
CY2021Q4 gpac Common Stock One Value
CommonStockOneValue
1000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14949000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25129000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-14948000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-25128000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
302337000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
301100000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1210000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
992000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1731000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3343000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1210000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-992000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1731000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3343000 usd
CY2022Q3 us-gaap Interest Income Other
InterestIncomeOther
1466000 usd
CY2021Q3 us-gaap Interest Income Other
InterestIncomeOther
8000 usd
us-gaap Interest Income Other
InterestIncomeOther
1946000 usd
us-gaap Interest Income Other
InterestIncomeOther
68000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
800000 usd
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1868000 usd
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2490000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11986000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8250000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2124000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
1506000 usd
us-gaap Net Income Loss
NetIncomeLoss
12201000 usd
us-gaap Net Income Loss
NetIncomeLoss
4175000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-15605000 usd
CY2022Q3 gpac Accretion In Value Of Class A Ordinary Shares Subject To Redemption
AccretionInValueOfClassAOrdinarySharesSubjectToRedemption
1467000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2124000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-14948000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-25128000 usd
gpac Accretion In Value Of Class A Ordinary Shares Subject To Redemption
AccretionInValueOfClassAOrdinarySharesSubjectToRedemption
2021000 usd
us-gaap Net Income Loss
NetIncomeLoss
12201000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-14948000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-27164000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
1506000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-25658000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
20000 usd
gpac Proceeds From Sale
ProceedsFromSale
5566667 shares
gpac Private Placement Warrants Per Shares
PrivatePlacementWarrantsPerShares
1.5
gpac Fair Value Per Warrants
FairValuePerWarrants
1.41
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
501000 usd
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-30354000 usd
us-gaap Net Income Loss
NetIncomeLoss
4175000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-25658000 usd
us-gaap Net Income Loss
NetIncomeLoss
12201000 usd
us-gaap Net Income Loss
NetIncomeLoss
4175000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
1946000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
68000 usd
gpac Cost Of Issuing Warrants
CostOfIssuingWarrants
800000 usd
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
usd
gpac Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
11986000 usd
gpac Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
8250000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-114000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
256000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
260000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
362000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2682000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-995000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-917000 usd
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
300000000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
300000000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
8350000 usd
gpac Payment Of Underwriting Discounts
PaymentOfUnderwritingDiscounts
6000000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
285000 usd
gpac Advances And Payment Of Notes Payable
AdvancesAndPaymentOfNotesPayable
-400000 usd
gpac Advances And Payment Of Notes Payable
AdvancesAndPaymentOfNotesPayable
199000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
400000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
301866000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-595000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
949000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
842000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
247000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
969000 usd
gpac Deferred Underwriter Compensation
DeferredUnderwriterCompensation
10500000 usd
gpac Initial Warrant Liability In Connection With Initial Public Offering And Private Placement
InitialWarrantLiabilityInConnectionWithInitialPublicOfferingAndPrivatePlacement
21949000 usd
gpac Offering Costs Included In Offering Costs Payable And Accrued
OfferingCostsIncludedInOfferingCostsPayableAndAccrued
70000 usd
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
300000000 usd
CY2021Q1 gpac Trust Account
TrustAccount
300000000 usd
us-gaap Interest Expense
InterestExpense
100000 usd
gpac Shares Redeem Percentage
SharesRedeemPercentage
1 pure
gpac Taxes Payable On Interest Earned Percentage
TaxesPayableOnInterestEarnedPercentage
0.80 pure
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5000001 usd
us-gaap Business Combination Acquired Receivables Description
BusinessCombinationAcquiredReceivablesDescription
” The amount in the Trust Account is initially funded at $10.00 per public Class A ordinary share ($300,000,000 held in the Trust Account divided by 30,000,000 public shares).
gpac Description Of Business Combination
DescriptionOfBusinessCombination
The Company will have until the end of the Combination Period to complete its Initial Business Combination or until the end of any extension period that may be proposed to and approved by the Company’s shareholders in the form of an amendment to the Company’s amended and restated memorandum and articles of association. If the Company does not complete a Business Combination within this period of time, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public Class A ordinary shares for a per share pro rata portion of the Trust Account, including interest earned on funds held in the trust account and not previously released to pay income taxes (less up to $100,000 of such net interest to pay dissolution expenses) and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of the Company’s net assets to its creditors and remaining shareholders, as part of its plan of dissolution and liquidation. The initial shareholders have entered into letter agreements with us, pursuant to which they have waived their rights to participate in any redemption with respect to their Founders Shares; however, if the initial shareholders or any of the Company’s officers, directors or affiliates acquire Class A ordinary shares in or after the Public Offering, they will be entitled to a pro rata share of the Trust Account with respect to the Class A ordinary shares so acquired upon the Company’s redemption or liquidation in the event the Company does not complete a Business Combination within the Combination Period.
CY2022Q3 us-gaap Cash
Cash
247000 usd
gpac Negative Working Capital
NegativeWorkingCapital
3514000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Concentration of Credit Risk:</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5000001 usd
gpac Public Shares
PublicShares
30000000 shares
CY2021 gpac Public Shares
PublicShares
30000000 shares
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Use of Estimates:</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed balance sheet and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant estimates included in these condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
gpac Total Offering Cost
TotalOfferingCost
17054000 usd
gpac Underwriters Discount
UnderwritersDiscount
16500000 usd
us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
16254000 usd
us-gaap Other Expenses
OtherExpenses
800000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
300000000 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
14100000 usd
gpac Offering Costs
OfferingCosts
16254000 usd
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
30354000 usd
us-gaap Temporary Equity Issue Period Increase Or Decrease
TemporaryEquityIssuePeriodIncreaseOrDecrease
300000000 usd
gpac Accretion Of Carrying Value To Redemption Value Since Public Offering
AccretionOfCarryingValueToRedemptionValueSincePublicOffering
2021000 usd
CY2022Q3 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
302021000 usd
CY2021Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
30000000 shares
CY2021Q1 gpac Share Purchase Price
SharePurchasePrice
10
CY2022Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
gpac Redeemable Warrants
RedeemableWarrants
0.01
gpac Ordinary Shares Equals Exceeds
OrdinarySharesEqualsExceeds
18
gpac Underwriting Discount Percentage
UnderwritingDiscountPercentage
0.02 pure
us-gaap Other Underwriting Expense
OtherUnderwritingExpense
6000000 usd
gpac Deferred Underwriting Percentage
DeferredUnderwritingPercentage
0.035 pure
CY2022Q3 gpac Deferred Underwriting Fees Payable
DeferredUnderwritingFeesPayable
10500000 usd
CY2021Q1 gpac Founder Share Vesting Description
FounderShareVestingDescription
The Founder Shares are substantially identical to the Class A ordinary shares included in the Units sold in the Public Offering except that the Founder Shares automatically convert into Class A ordinary shares at the time of the Initial Business Combination, or at any time prior thereto at the option of the holder, and are subject to certain transfer restrictions, as described in more detail below, and the Founder Shares are subject to vesting as follows: 50% upon the completion of a Business Combination and then 12.5% on each of the attainment of Return to Shareholders (as defined in the agreement) exceeding 20%, 30%, 40% and 50%. Certain events, as defined in the agreement, could trigger an immediate vesting under certain circumstances. Founder Shares that do not vest within an eight-year period from the closing of the Business Combination will be cancelled.
CY2020Q4 gpac Aggregate Loan Amount
AggregateLoanAmount
300000 usd
CY2020Q4 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
1000 usd
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
199000 usd
CY2022Q3 gpac Principal Amount
PrincipalAmount
2000000 usd
CY2022Q3 gpac Outstanding Principal Balance
OutstandingPrincipalBalance
400000 usd
us-gaap Sponsor Fees
SponsorFees
25000 usd
CY2022Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
75000 usd
CY2021Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
75000 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
225000 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
213000 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
15566667 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
15566667 shares
us-gaap Results Of Operations Dry Hole Costs
ResultsOfOperationsDryHoleCosts
800000 usd
CY2021Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
gpac Cost Of Issuing Warrants
CostOfIssuingWarrants
usd
CY2022Q3 us-gaap Fair Value Concentration Of Risk Federal Funds Sold And Securities Borrowed Or Purchased Under Agreements To Resell
FairValueConcentrationOfRiskFederalFundsSoldAndSecuritiesBorrowedOrPurchasedUnderAgreementsToResell
300000000 usd
gpac Us Government Treasury Bills Maturity
USGovernmentTreasuryBillsMaturity
P180D
gpac Common Stock In Total
CommonStockInTotal
550000000 shares
us-gaap Business Combination Control Obtained Description
BusinessCombinationControlObtainedDescription
The Founder Shares are subject to vesting as follows: 50% upon the completion of a Business Combination and then an additional 12.5% on the attainment of each of a series of certain “shareholder return” targets exceeding 20%, 30%, 40% and 50%, as further defined in the agreement. Certain events, as defined in the agreement, could trigger an immediate vesting under certain circumstances. Founder Shares that do not vest within an eight-year period from the closing of the Business Combination will be cancelled. 
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
gpac Payment Of Underwriting Discounts
PaymentOfUnderwritingDiscounts
usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
gpac Deferred Underwriter Compensation
DeferredUnderwriterCompensation
usd
gpac Initial Warrant Liability In Connection With Initial Public Offering And Private Placement
InitialWarrantLiabilityInConnectionWithInitialPublicOfferingAndPrivatePlacement
usd
gpac Offering Costs Included In Offering Costs Payable And Accrued
OfferingCostsIncludedInOfferingCostsPayableAndAccrued
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001831979

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001213900-22-069750-index-headers.html Edgar Link pending
0001213900-22-069750-index.html Edgar Link pending
0001213900-22-069750.txt Edgar Link pending
0001213900-22-069750-xbrl.zip Edgar Link pending
f10q0922ex31-1_globalpart2.htm Edgar Link pending
f10q0922ex31-2_globalpart2.htm Edgar Link pending
f10q0922ex32-1_globalpart2.htm Edgar Link pending
f10q0922ex32-2_globalpart2.htm Edgar Link pending
f10q0922_globalpart2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gpac-20220930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gpac-20220930_cal.xml Edgar Link unprocessable
gpac-20220930_def.xml Edgar Link unprocessable
gpac-20220930_lab.xml Edgar Link unprocessable
gpac-20220930_pre.xml Edgar Link unprocessable
f10q0922_globalpart2_htm.xml Edgar Link completed